Atlas Trials

S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP

Clinical trial NCT06188702 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06188702
Sponsor
Servier Bio-Innovation LLC
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
MTAP-deleted Solid Tumors
Start date
2024-04-29
Primary completion
2027-05-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.